All the marblesThe global alzheimer's therapeutics market size was valued at USD 4.05 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 19.99% from 2023 to 2030. The rising prevalence of Alzheimer's Disease (AD) and approval of disease-modifying therapies are expected to fuel market growth.
So to sound like a broken record and to appeal to your sense of greed, if and I do mean if you show significant efficacy with minimal side effects, then you beat all the majors in this field and will take off on one of musks rockets. We will have an indication sometime in June, but our contracted CRO will be able to tell us after a month or so of dosing the first cohort. Gut wrenching times ahead and if this works all out other antibodies will get fast tracked.